| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $82.5M | — |
| R&D Expense | $697.3M | +288.6% |
| SG&A Expense | $115.9M | +199.6% |
| Operating Income | -$730.7M | -235.0% |
| Pre-tax Income | -$760.0M | -254.4% |
| Income Tax | -$4.5M | — |
| Net Income | -$755.5M | -252.3% |
| EPS (Basic) | -$1.22 | -54.4% |
| EPS (Diluted) | -$1.22 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.61B | — |
| Current Assets | $1.68B | — |
| Total Assets | $3.69B | — |
| Current Liabilities | $90.7M | — |
| Total Liabilities | $348.4M | — |
| Stockholders' Equity | $3.34B | — |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$563.3M | -193.6% |
| Capital Expenditures | $48.1M | +618.4% |
| Investing Cash Flow | $249.9M | -27.2% |
| Financing Cash Flow | $1.54B | — |
| Free Cash Flow | -$611.3M | -207.9% |
| -54.4% |